
New German expert consensus provides first risk-based recommendations for sNPWT use in closed surgical incisions
GlobeNewsWire
公開日時: Jul 09, 2026, 03:00 PM GMT+9
Sentiment Analysis
New German expert consensus provides first risk-based recommendations for sNPWT use in closed surgical incisions July 09, 2026 02:00 ET | Source: Smith & Nephew UK Ltd Smith & Nephew UK Ltd Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces the publication of new consensus-based guidance - developed independently by expert clinicians for the use of single-use negative pressure wound therapy (sNPWT) in closed surgical incisions. The guidance is supported by practical clinical practice recommendations for Germany. Published in internationally recognised journal of surgery Die Chirurgie, the new German consensus was supported by Smith+Nephew, a pioneer in sNPWT and manufacturer of the PICO ™ 7 sNPWT system. New consensus provides practical framework for post-surgical care This new interdisciplinary consensus is the first in Germany to translate clinical evidence into practical real-world guidance.¹ It highlights the importance of structured preventative strategies in reducing the risk of post-surgical complications such as prolonged wound drainage and seroma formation that are known to adversely affect the healing process.¹ This is critical to helping avoid complications at an early stage, and contributes to more predictable treatment outcomes¹. sNPWT recommended for at-risk patients Backed by strong clinical evidence, the consensus identifies sNPWT as a targeted preventive option for patients at increased risk of postoperative wound complications.¹ Risk factors include obesity, diabetes mellitus, smoking, and procedure-related factors such as prolonged surgical duration or revision surgery.¹ Having a clearly-defined patient criteria enables health professionals to tailor interventions based on individual risk profiles and supports clinical decision-making.¹ The new expert consensus also defines clear treatment boundaries, recommending sNPWT for w...
Source: GlobeNewsWire
個別の投資に関する推奨やアドバイスを提供することを意図しておりません。ここで述べられている意見や見解は、あくまでも各記事の個人的見解です。